[Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
Identifieur interne : 000050 ( 2020/Analysis ); précédent : 000049; suivant : 000051[Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
Auteurs : Cai-Xia Yan [République populaire de Chine] ; Jia Li [République populaire de Chine] ; Xin Shen [République populaire de Chine] ; Li Luo [République populaire de Chine] ; Yan Li [République populaire de Chine] ; Ming-Yuan Li [République populaire de Chine]Source :
- Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition [ 1672-173X ] ; 2020.
Descripteurs français
- KwdFr :
- Anticorps monoclonaux (usage thérapeutique), Coronavirus du syndrome respiratoire du Moyen-Orient, Humains, Immunisation passive, Infections à coronavirus (), Infections à coronavirus (traitement médicamenteux), Interférons (usage thérapeutique), Pandémies (), Plasma sanguin, Pneumopathie virale (), Pneumopathie virale (traitement médicamenteux), Produits biologiques (usage thérapeutique), Syndrome respiratoire aigu sévère, Vaccins antiviraux.
- MESH :
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Anticorps monoclonaux, Interférons, Produits biologiques.
- Coronavirus du syndrome respiratoire du Moyen-Orient, Humains, Immunisation passive, Infections à coronavirus, Pandémies, Plasma sanguin, Pneumopathie virale, Syndrome respiratoire aigu sévère, Vaccins antiviraux.
English descriptors
- KwdEn :
- Antibodies, Monoclonal (therapeutic use), Betacoronavirus (drug effects), Betacoronavirus (immunology), Biological Products (therapeutic use), Coronavirus Infections (drug therapy), Coronavirus Infections (prevention & control), Coronavirus Infections (therapy), Drug Development, Humans, Immunization, Passive, Interferons (therapeutic use), Middle East Respiratory Syndrome Coronavirus, Pandemics (prevention & control), Plasma, Pneumonia, Viral (drug therapy), Pneumonia, Viral (prevention & control), Severe Acute Respiratory Syndrome, Viral Vaccines.
- MESH :
- chemical , therapeutic use : Antibodies, Monoclonal, Biological Products, Interferons.
- drug effects : Betacoronavirus.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- immunology : Betacoronavirus.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- therapy : Coronavirus Infections.
- Drug Development, Humans, Immunization, Passive, Middle East Respiratory Syndrome Coronavirus, Plasma, Severe Acute Respiratory Syndrome, Viral Vaccines.
Abstract
Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), has become a Public Health Emergency of International Concern. Due to the large infection population, broad transmissibility and high mortality, it is urgent to find out the efficient and specific methods to prevent and treat COVID-19. As biological products have broadly applied in the prevention and treatment of severe epidemic diseases, they are promising in blocking novel coronavirus infection. According to the research advances of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), we reviewed the potential application of biological products such as interferon, convalescent plasma, intestinal micro-ecological regulators, vaccines and therapeutic antibodies, etc. , on prevention and treatment of COVID-19. May this review be helpful for conquering COVID-19 in the near future.
DOI: 10.12182/20200360506
PubMed: 32220178
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000487
- to stream PubMed, to step Curation: 000487
- to stream PubMed, to step Checkpoint: 000035
- to stream Ncbi, to step Merge: 003580
- to stream Ncbi, to step Curation: 003580
- to stream Ncbi, to step Checkpoint: 003580
- to stream Main, to step Merge: 000049
- to stream Main, to step Curation: 000050
- to stream Main, to step Exploration: 000050
- to stream 2020, to step Extraction: 000050
Links to Exploration step
pubmed:32220178Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].</title><author><name sortKey="Yan, Cai Xia" sort="Yan, Cai Xia" uniqKey="Yan C" first="Cai-Xia" last="Yan">Cai-Xia Yan</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Li, Jia" sort="Li, Jia" uniqKey="Li J" first="Jia" last="Li">Jia Li</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Shen, Xin" sort="Shen, Xin" uniqKey="Shen X" first="Xin" last="Shen">Xin Shen</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Luo, Li" sort="Luo, Li" uniqKey="Luo L" first="Li" last="Luo">Li Luo</name><affiliation wicri:level="1"><nlm:affiliation>Chengdu Institute of Biological Products, Chengdu 610023, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Chengdu Institute of Biological Products, Chengdu 610023</wicri:regionArea><wicri:noRegion>Chengdu 610023</wicri:noRegion></affiliation></author><author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Li, Ming Yuan" sort="Li, Ming Yuan" uniqKey="Li M" first="Ming-Yuan" last="Li">Ming-Yuan Li</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Medical Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32220178</idno><idno type="pmid">32220178</idno><idno type="doi">10.12182/20200360506</idno><idno type="wicri:Area/PubMed/Corpus">000487</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000487</idno><idno type="wicri:Area/PubMed/Curation">000487</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000487</idno><idno type="wicri:Area/PubMed/Checkpoint">000035</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000035</idno><idno type="wicri:Area/Ncbi/Merge">003580</idno><idno type="wicri:Area/Ncbi/Curation">003580</idno><idno type="wicri:Area/Ncbi/Checkpoint">003580</idno><idno type="wicri:doubleKey">1672-173X:2020:Yan C:biological:product:development</idno><idno type="wicri:Area/Main/Merge">000049</idno><idno type="wicri:Area/Main/Curation">000050</idno><idno type="wicri:Area/Main/Exploration">000050</idno><idno type="wicri:Area/2020/Extraction">000050</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].</title><author><name sortKey="Yan, Cai Xia" sort="Yan, Cai Xia" uniqKey="Yan C" first="Cai-Xia" last="Yan">Cai-Xia Yan</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Li, Jia" sort="Li, Jia" uniqKey="Li J" first="Jia" last="Li">Jia Li</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Shen, Xin" sort="Shen, Xin" uniqKey="Shen X" first="Xin" last="Shen">Xin Shen</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Luo, Li" sort="Luo, Li" uniqKey="Luo L" first="Li" last="Luo">Li Luo</name><affiliation wicri:level="1"><nlm:affiliation>Chengdu Institute of Biological Products, Chengdu 610023, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Chengdu Institute of Biological Products, Chengdu 610023</wicri:regionArea><wicri:noRegion>Chengdu 610023</wicri:noRegion></affiliation></author><author><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name><affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>State Key Laboratory of Oral Diseases , National Clinical Research Center for Oral Diseases，West China Hospital of Stomatology, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author><author><name sortKey="Li, Ming Yuan" sort="Li, Ming Yuan" uniqKey="Li M" first="Ming-Yuan" last="Li">Ming-Yuan Li</name><affiliation wicri:level="1"><nlm:affiliation>Department of Medical Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu 610041, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Medical Microbiology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu 610041</wicri:regionArea><wicri:noRegion>Chengdu 610041</wicri:noRegion></affiliation></author></analytic><series><title level="j">Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition</title><idno type="ISSN">1672-173X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal (therapeutic use)</term><term>Betacoronavirus (drug effects)</term><term>Betacoronavirus (immunology)</term><term>Biological Products (therapeutic use)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (therapy)</term><term>Drug Development</term><term>Humans</term><term>Immunization, Passive</term><term>Interferons (therapeutic use)</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Pandemics (prevention & control)</term><term>Plasma</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (prevention & control)</term><term>Severe Acute Respiratory Syndrome</term><term>Viral Vaccines</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps monoclonaux (usage thérapeutique)</term><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term><term>Humains</term><term>Immunisation passive</term><term>Infections à coronavirus ()</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Interférons (usage thérapeutique)</term><term>Pandémies ()</term><term>Plasma sanguin</term><term>Pneumopathie virale ()</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Produits biologiques (usage thérapeutique)</term><term>Syndrome respiratoire aigu sévère</term><term>Vaccins antiviraux</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal</term><term>Biological Products</term><term>Interferons</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Pandemics</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux</term><term>Interférons</term><term>Produits biologiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Development</term><term>Humans</term><term>Immunization, Passive</term><term>Middle East Respiratory Syndrome Coronavirus</term><term>Plasma</term><term>Severe Acute Respiratory Syndrome</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Coronavirus du syndrome respiratoire du Moyen-Orient</term><term>Humains</term><term>Immunisation passive</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Plasma sanguin</term><term>Pneumopathie virale</term><term>Syndrome respiratoire aigu sévère</term><term>Vaccins antiviraux</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), has become a Public Health Emergency of International Concern. Due to the large infection population, broad transmissibility and high mortality, it is urgent to find out the efficient and specific methods to prevent and treat COVID-19. As biological products have broadly applied in the prevention and treatment of severe epidemic diseases, they are promising in blocking novel coronavirus infection. According to the research advances of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), we reviewed the potential application of biological products such as interferon, convalescent plasma, intestinal micro-ecological regulators, vaccines and therapeutic antibodies, etc. , on prevention and treatment of COVID-19. May this review be helpful for conquering COVID-19 in the near future.</div></front></TEI><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Yan, Cai Xia" sort="Yan, Cai Xia" uniqKey="Yan C" first="Cai-Xia" last="Yan">Cai-Xia Yan</name></noRegion><name sortKey="Li, Jia" sort="Li, Jia" uniqKey="Li J" first="Jia" last="Li">Jia Li</name><name sortKey="Li, Ming Yuan" sort="Li, Ming Yuan" uniqKey="Li M" first="Ming-Yuan" last="Li">Ming-Yuan Li</name><name sortKey="Li, Yan" sort="Li, Yan" uniqKey="Li Y" first="Yan" last="Li">Yan Li</name><name sortKey="Luo, Li" sort="Luo, Li" uniqKey="Luo L" first="Li" last="Luo">Li Luo</name><name sortKey="Shen, Xin" sort="Shen, Xin" uniqKey="Shen X" first="Xin" last="Shen">Xin Shen</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000050 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000050 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32220178
|texte= [Biological Product Development Strategies for Prevention and Treatment of Coronavirus Disease 2019].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32220178" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |